Clinical Trial Update: Safety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH [Phase 1]

View source ↗

Summary

Phase 1 safety evaluation of intravenous Tc-99m tilmanocept and imaging with sulfur colloid in subjects with and without nonalcoholic steatohepatitis has been t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Sulfur Colloid (Sulfur colloid)
• Tilmanocept (Tilmanocept)

Snippet

Sponsor: Navidea Biopharmaceuticals | Conditions: Nonalcoholic Steatohepatitis, NASH - Nonalcoholic Steatohepatitis | Phase 1 | Status: TERMINATED